Calamos Advisors LLC Sells 36,163 Shares of Danaher Corporation $DHR

Calamos Advisors LLC lessened its stake in shares of Danaher Corporation (NYSE:DHRFree Report) by 13.9% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 223,518 shares of the conglomerate’s stock after selling 36,163 shares during the period. Calamos Advisors LLC’s holdings in Danaher were worth $44,315,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. Meridian Financial Partners LLC bought a new position in Danaher in the 3rd quarter worth about $896,000. Aljian Capital Management LLC raised its holdings in Danaher by 8.9% in the third quarter. Aljian Capital Management LLC now owns 3,830 shares of the conglomerate’s stock worth $759,000 after buying an additional 313 shares during the last quarter. Hunter Associates Investment Management LLC lifted its stake in shares of Danaher by 16.0% in the third quarter. Hunter Associates Investment Management LLC now owns 1,215 shares of the conglomerate’s stock worth $240,000 after buying an additional 168 shares in the last quarter. Forefront Wealth Partners LLC bought a new position in shares of Danaher in the third quarter worth approximately $292,000. Finally, Ascent Group LLC increased its position in shares of Danaher by 120.8% during the third quarter. Ascent Group LLC now owns 9,912 shares of the conglomerate’s stock valued at $1,965,000 after acquiring an additional 5,422 shares in the last quarter. 79.05% of the stock is owned by institutional investors.

Insider Buying and Selling at Danaher

In other news, SVP Brian W. Ellis sold 21,776 shares of Danaher stock in a transaction that occurred on Wednesday, November 12th. The shares were sold at an average price of $219.23, for a total transaction of $4,773,952.48. Following the sale, the senior vice president owned 14,553 shares in the company, valued at $3,190,454.19. This trade represents a 59.94% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Teri List sold 3,298 shares of the business’s stock in a transaction on Tuesday, November 18th. The stock was sold at an average price of $226.50, for a total transaction of $746,997.00. Following the completion of the transaction, the director directly owned 20,762 shares in the company, valued at $4,702,593. This trade represents a 13.71% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 30,248 shares of company stock valued at $6,609,663 in the last three months. 11.20% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

DHR has been the topic of several analyst reports. JPMorgan Chase & Co. upped their price objective on Danaher from $260.00 to $270.00 and gave the company an “overweight” rating in a research report on Wednesday, October 22nd. HSBC upped their price target on Danaher from $255.00 to $270.00 and gave the company a “buy” rating in a report on Monday, December 1st. Wells Fargo & Company lifted their price objective on Danaher from $230.00 to $240.00 and gave the stock an “equal weight” rating in a report on Monday, December 15th. Weiss Ratings reissued a “hold (c)” rating on shares of Danaher in a research report on Monday. Finally, Evercore ISI raised their price target on shares of Danaher from $226.00 to $245.00 and gave the company an “outperform” rating in a report on Tuesday, October 7th. Twenty-one investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $248.25.

Get Our Latest Analysis on DHR

Danaher Stock Up 0.1%

DHR opened at $230.76 on Wednesday. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $258.23. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.10 and a current ratio of 1.52. The stock has a market cap of $162.99 billion, a price-to-earnings ratio of 47.58, a price-to-earnings-growth ratio of 4.46 and a beta of 0.89. The firm’s fifty day moving average is $223.31 and its 200 day moving average is $208.61.

Danaher (NYSE:DHRGet Free Report) last posted its quarterly earnings results on Monday, October 20th. The conglomerate reported $1.89 EPS for the quarter, beating analysts’ consensus estimates of $1.72 by $0.17. The business had revenue of $6.05 billion for the quarter, compared to analysts’ expectations of $6 billion. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The business’s quarterly revenue was up 4.4% on a year-over-year basis. During the same period last year, the firm earned $1.71 earnings per share. On average, sell-side analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Friday, December 26th will be paid a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 0.6%. The ex-dividend date is Friday, December 26th. Danaher’s dividend payout ratio is presently 26.39%.

Danaher Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Recommended Stories

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.